Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
29232 | 156 | 36.5 | 72% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
132 | 22818 | ANGIOTENSIN II//ANGIOTENSIN 1 7//RENIN ANGIOTENSIN SYSTEM |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | COLD INDUCED HYPERTENSION | Author keyword | 51 | 91% | 13% | 21 |
2 | ANTISENSE ELEMENTS | Author keyword | 3 | 50% | 3% | 4 |
3 | AT1 RECEPTOR ANTISENSE | Author keyword | 1 | 100% | 1% | 2 |
4 | HYPERTENSION 2K1C | Author keyword | 1 | 100% | 1% | 2 |
5 | HYPERTENSION COLD INDUCED | Author keyword | 1 | 100% | 1% | 2 |
6 | RENAL AND CARDIAC PATHOPHYSIOLOGY | Author keyword | 1 | 100% | 1% | 2 |
7 | RENOVASCULAR RESPONSIVENESS | Author keyword | 1 | 100% | 1% | 2 |
8 | ANGIOTENSIN II INDUCED DRINKING | Author keyword | 1 | 30% | 2% | 3 |
9 | AT1 RECEPTOR MRNA | Author keyword | 1 | 50% | 1% | 1 |
10 | D 1 PROPRANOLOL | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DIPSOGENIC RESPONSIVENESS | 17 | 100% | 5% | 8 |
2 | TYPE 1 RECEPTOR ANTISENSE | 15 | 68% | 8% | 13 |
3 | PROLONGED REDUCTION | 7 | 57% | 5% | 8 |
4 | VIRAL VECTOR DELIVERY | 6 | 58% | 4% | 7 |
5 | DELIVERY ATTENUATES HYPERTENSION | 5 | 33% | 8% | 13 |
6 | HVJ LIPOSOME DELIVERY | 3 | 100% | 2% | 3 |
7 | COLD INDUCED HYPERTENSION | 2 | 33% | 4% | 6 |
8 | CHIMERIC HAMMERHEAD RIBOZYME | 1 | 50% | 1% | 1 |
9 | II TYPE I | 1 | 50% | 1% | 1 |
10 | INTRARENAL ENDOTHELIN | 0 | 33% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Gene therapy for hypertension: sense and antisense strategies | 2001 | 13 | 25 | 52% |
Retrovirally mediated delivery of angiotensin II type 1 receptor antisense in vitro and in vivo | 2000 | 0 | 3 | 100% |
Historic perspectives and recent advances in major animal models of hypertension | 2005 | 22 | 52 | 25% |
Targeting of the renin-angiotensin system by antisense gene therapy: a possible strategy for the long-term control of hypertension | 2000 | 19 | 43 | 26% |
Gene therapy for hypertension: The preclinical data | 2002 | 5 | 37 | 43% |
Gene-based therapy for hypertension do preclinical data suggest a promising future? | 2007 | 4 | 70 | 17% |
Current perspectives on the use of gene therapy for hypertension | 2000 | 11 | 36 | 25% |
Large-scale production of retroviral vectors for systemic gene delivery | 2002 | 3 | 11 | 36% |
The potential use of gene therapy in the control of hypertension | 1999 | 2 | 17 | 41% |
Essential hypertension seems to result from metatonin-induced epigenetic modifications in area postrema | 2006 | 23 | 100 | 9% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LEAD DEV | 1 | 50% | 0.6% | 1 |
2 | REGIERUNG UNTERFRANKEN | 1 | 50% | 0.6% | 1 |
3 | PHARM PHARMACODYNAM | 1 | 29% | 1.3% | 2 |
4 | PHYSIOL FUNCT GENOMICS | 1 | 22% | 1.3% | 2 |
5 | ROBERT MARY CADE | 0 | 33% | 0.6% | 1 |
6 | BOWMAN GRAY MED HYPERTENS | 0 | 25% | 0.6% | 1 |
7 | FUNC GENOM | 0 | 25% | 0.6% | 1 |
8 | BIOCLIMATOL MED | 0 | 10% | 1.3% | 2 |
9 | EVELYN F WILLIAM MCKNIGHT BRAIN | 0 | 14% | 0.6% | 1 |
10 | PHYSIOL VVI | 0 | 11% | 0.6% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000161297 | LITERARY PHILOSOPHY//P53 GENE PRODUCT//NUTR CONSUMER PROD |
2 | 0.0000158094 | HEMAGGLUTINATING VIRUS OF JAPAN//GAX//HVJ LIPOSOME |
3 | 0.0000131514 | SODIUM APPETITE//SUBFORNICAL ORGAN//THIRST |
4 | 0.0000126006 | VIBRISSAL MOVEMENTS//HYPOTHALAMO//ADRENOBLOCKERS |
5 | 0.0000123042 | ADRENAL RENIN//ANGIOTENSINOGEN//TISSUE RENIN |
6 | 0.0000115278 | HEAT WAVES//HEAT RELATED MORTALITY//HEAT WAVE |
7 | 0.0000093272 | AT2 RECEPTOR//COMPOUND 21//ANGIOTENSIN RECEPTORS |
8 | 0.0000073439 | ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT//ANTISENSE RESEARCH AND DEVELOPMENT//ANTISENSE |
9 | 0.0000066544 | KALLIKREIN//KALLISTATIN//RENAL KALLIKREIN KININ SYSTEM |
10 | 0.0000066467 | CARDIAC SYMPATHETIC AFFERENT REFLEX//ROSTRAL VENTROLATERAL MEDULLA//ADV CARDIOVASC REGULAT THER EUT |